Blog
Amendment to the Guideline on the Labeling of Narcotic and Psychotropic Drugs to Clarify Packaging Requirements
The Public Health Institute of Chile (ISP) has published Exempt Resolution No. 1889, which amends the “Guideline for the Regulation of Labeling and Packaging of ...
Read More →
New Procedure for the Granting of Marketing Authorizations for Biological Products
The Chilean Public Health Institute (ISP) has issued Resolution Exenta No. E679/2025, establishing an internal procedure for the application of a reliance mechanism in the ...
Read More →
New requirements for the labeling of high-risk medications
On January 19, 2024, the Chilean Public Health Institute (ISP) issued exempt resolution No. 459 approving guidelines and requirements for the labeling of high-risk medications. ...
Read More →
Security Update for DENOSUMAB Information
On November 7, 2023, the Public Health Institute of Chile (ISP) issued the exempt resolution No. 5855 instructing the update of information leaflets for healthcare ...
Read More →
Suspension of “Export Pharmaceutical Product Registration.”
On July 6, 2023, the Chilean Institute of Public Health (ISP) issued decree No. 1932, wherein the health authority suspends service code 44112130 “Export Pharmaceutical ...
Read More →
Technical guide of recommendations on labeling of cosmetic products
On April 21, 2023, the Chilean Public Health Institute (ISP) issued Resolution No. 1020 authorizing the “Technical guide of recommendations on labeling of cosmetic products”. ...
Read More →
Technical guide of requirements for the sanitary registration of allergens
On February 20, 2023, the Institute of Public Health has published the “Technical guide of requirements for the sanitary registry of allergens”. In this document, ...
Read More →
Guide to Good Manufacturing Practices (GMP) for medical devices in Chile
Through exempt resolution No. 106, dated January 17, 2023, the Chilean Institute of Public Health through the Department of the National Agency for Medical Devices, ...
Read More →
Obligations for license holders of oral contraceptive products
On November 30, 2022, the Institute of Public Health has issued resolution No. 5250 that complements resolution No. 2198/2022 that established the obligations addressed to ...
Read More →
Modifies the exempt resolution No. 395/2022, of the ISP, incorporating a term to make the labeling required to be updated in the renewal of the sanitary registration of pharmaceutical products.
Modifies the exempt resolution No. 395/2022, of the ISP, incorporating a term to make the labeling required to be updated in the renewal of the ...
Read More →
New requirements for oral contraceptives
Considering the alerts issued by the health authority regarding contraceptives, on June 6th, 2022, resolution No. 2198 (May 19, 2022) was published in the official ...
Read More →
Update of the list of reference products for demonstration of biosimilarity
On November 16, 2021, the Ministry of Health has issued the Exempt Decree No. 62 that modifies the exempt decree No. 945 that approves the ...
Read More →